Keyphrases
Tumor
100%
Epidermal Growth Factor Receptor
100%
Statins
100%
Statin Therapy
100%
Receptor Density
60%
Cell Surface
60%
Prostate-specific Antigen
60%
Cell Membrane
40%
Membrane Receptors
40%
Xenograft
40%
Simvastatin
40%
Lovastatin
40%
Endocytic Proteins
40%
Rosuvastatin
40%
Therapeutic Target
20%
Tumor Cells
20%
Antigen Receptor
20%
Cholesterol
20%
Therapeutic Antibody
20%
Overexpressing
20%
Monoclonal Antibody
20%
Extracellular Domain
20%
Pharmacologic
20%
Clathrin
20%
In Vivo Analysis
20%
Drug Use
20%
Labeled Antibody
20%
Antibody Binding
20%
Hypercholesterolemia
20%
Caveolin-1 (Cav-1)
20%
Zirconium-89 (89Zr)
20%
Surface Level
20%
Cetuximab
20%
Endocytic Pathway
20%
Receptor-mediated Endocytosis
20%
Receptor Recycling
20%
Small Animal PET
20%
Poor Response
20%
Dynamic Mechanism
20%
Tumor Therapeutics
20%
Tumor Biomarkers
20%
Tumor Accumulation
20%
Translational Significance
20%
Dynamin
20%
Panitumumab
20%
Cavin
20%
Endophilin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Receptor
100%
Epidermal Growth Factor Receptor
100%
Statin (Protein)
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Prostate Specific Membrane Antigen
60%
Membrane Receptor
40%
Simvastatin
40%
Mevinolin
40%
Rosuvastatin
40%
Monoclonal Antibody
20%
Hypercholesterolemia
20%
Membrane Antigen
20%
Lymphocyte Antigen Receptor
20%
Zirconium 89
20%
Cetuximab
20%
Tumor Marker
20%
Clathrin
20%
Dynamin
20%
Panitumumab
20%
Caveolin 1
20%
Endophilin
20%
Polyethylene Terephthalate
20%
Neuroscience
Epidermal Growth Factor Receptor
100%
Statin
100%
Receptor
71%
Prostate Specific Membrane Antigen
42%
Cell Membrane
28%
Membrane Receptor
28%
Lovastatin
28%
Simvastatin
28%
Rosuvastatin
28%
Monoclonal Antibody
14%
Therapeutic Antibodies
14%
Positron Emission Tomography
14%
Clathrin
14%
Endocytosis
14%
Membrane Antigen
14%
Lymphocyte Antigen Receptor
14%
Dynamin
14%
Cetuximab
14%
Endophilin
14%
Caveolin 1
14%
Panitumumab
14%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Statin
100%
Receptor Density
42%
Cell Membrane
28%
Simvastatin
28%
Lovastatin
28%
Rosuvastatin
28%
Avidity
14%
Downregulation
14%
Clathrin
14%
Monoclonal Antibody
14%
Hypercholesterolemia
14%
Caveolin 1
14%
Endocytosis
14%
Tumor Marker
14%
Therapeutic Antibodies
14%
Dynamin
14%
Cetuximab
14%
Panitumumab
14%